Fritz Schröder Opportunistic Prostate Screening May Not Save Lives! REFERENCE: AACR 2007, Los Angeles FRITZ SCHRÖDER, Erasmus University, Rotterdam Though elective screening appears to have reduced

Fritz Schröder
Opportunistic Prostate Screening May Not Save Lives!
REFERENCE: AACR 2007, Los Angeles
FRITZ SCHRÖDER, Erasmus University, Rotterdam
Though elective screening appears to have reduced the number of patients who die from prostate cancer in the United States, this has yet to be proven. A large European study is currently seeking to settle the matter, and one of the investigators, Fritz Schröder took part in a debate at the AACR entitled: Opportunistic Screening for Prostate Cancer: The Up and Down Sides of PSA Testing. Peter Goodwin talked with him about the dilemmas involved with prostate screening.

Peter Scardino
Debate on PSA Screening
REFERENCE: AACR 2007, Los Angeles
PETER SCARDINO, Memorial Sloan-Kettering Cancer Center, New York
The benefits of prostate cancer screening programs were questioned in a debate at the AACR conference in Los Angeles. Because the link between early detection and mortality is not simple, treatment risks could mean there is still an argument for watchful waiting in many patients. Peter Goodwin talked with Peter Scardino about the problems clinicians are facing in the age of the PSA test.
To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
Related Episodes

More Breast Cancer Cases in Younger Women since 2010 But Fewer Deaths
An interview with: Adetunji T. Toriola, MD, PhD, MPH, Professor of Surgery, Department of Surgery and Division of Public Health Sciences, Washington University School of Medicine and Siteman Cancer Ce

Fast, Accurate Artificial Intelligence Method to Diagnose and Classify Pediatric Sarcoma Anywhere
An interview with: Adam Thiesen, PhD Candidate, UConn Health, University of Connecticut and the Jackson Laboratory for Genomic Medicine, Farmington, CT And with: Jayesh Desai MD, Medical Oncologist,

Two Checkpoint Inhibitors in One Bispecific Molecule Improved Survival in Patients with High-Risk Gastric Cancer
An interview with: Jiafu Ji MD PhD DrPH FRCS, Fellow of the Chinese Academy of Medical Science, Professor and Chief, Gastrointestinal Cancer Center, Peking University Cancer Hospital, Beijing Institut
